(1)
Targeting Interleukin-6 Signaling With Tocilizumab in Atherosclerosis: A Meta-Analysis of Anti-Inflammatory Effects and Plaque Stabilization. OAIJMR 2025, 5 (1), 1-14. https://doi.org/10.37275/oaijmr.v5i1.686.